| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Director | Common Stock | 3,894 | $30,315 | $7.79 | 12 Sep 2025 | Direct |
| ZEVRA THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 30,000 | 29 May 2025 | Direct | ||
| ARTELO BIOSCIENCES, INC. | Director | Warrant (right to buy) | 12,566 | 28 Oct 2025 | Direct | ||
| Kintara Therapeutics, Inc. | Director | Options (Right to Buy) | 8,500 | 30 Aug 2023 | Direct | ||
| ARTELO BIOSCIENCES, INC. | Director | Stock Options (right to buy) | 292 | 30 Jan 2026 | Direct | ||
| ARTELO BIOSCIENCES, INC. | Director | Convertible Promissory Note | $25,000 | 01 May 2025 | By trust | ||
| ARTELO BIOSCIENCES, INC. | Director | Convertible Promissory Note | $19,793 | 28 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ARTL | ARTELO BIOSCIENCES, INC. | 30 Jan 2026 | 1 | $0 | 4 | Director | 02 Feb 2026, 16:45 |
| ARTL | ARTELO BIOSCIENCES, INC. | 28 Oct 2025 | 4 | -$5,207 | 4 | Director | 30 Oct 2025, 21:28 |
| ZVRA | ZEVRA THERAPEUTICS, INC. | 12 Sep 2025 | 1 | +$24,718 | 4 | Director | 16 Sep 2025, 16:15 |
| ZVRA | ZEVRA THERAPEUTICS, INC. | 29 May 2025 | 1 | $0 | 4 | Director | 30 May 2025, 21:39 |
| ARTL | ARTELO BIOSCIENCES, INC. | 01 May 2025 | 1 | +$25,000 | 4 | Director | 05 May 2025, 17:24 |
| ARTL | ARTELO BIOSCIENCES, INC. | 20 Dec 2024 | 1 | $0 | 4 | Director | 23 Dec 2024, 16:00 |
| ZVRA | ZEVRA THERAPEUTICS, INC. | 13 May 2024 | 1 | $0 | 4 | Director | 15 May 2024, 21:20 |
| ARTL | ARTELO BIOSCIENCES, INC. | 28 Feb 2024 | 10 | $0 | 4 | Director | 01 Mar 2024, 20:53 |
| HURA | Kintara Therapeutics, Inc. | 30 Aug 2023 | 1 | $0 | 4 | Director | 01 Sep 2023, 18:00 |
| ARTL | ARTELO BIOSCIENCES, INC. | 04 Aug 2023 | 1 | $0 | 4 | Director | 08 Aug 2023, 16:54 |
| ARTL | ARTELO BIOSCIENCES, INC. | 30 Jun 2023 | 1 | $0 | 4 | Director | 03 Jul 2023, 14:05 |
| ZVRA | ZEVRA THERAPEUTICS, INC. | 31 May 2023 | 1 | $0 | 4 | Director | 02 Jun 2023, 16:33 |
| ZVRA | ZEVRA THERAPEUTICS, INC. | 25 Apr 2023 | 1 | $0 | 4 | Director | 08 May 2023, 21:51 |
| ZVRA | ZEVRA THERAPEUTICS, INC. | 17 Mar 2023 | 1 | +$2,502 | 4 | Director | 21 Mar 2023, 16:32 |
| HURA | Kintara Therapeutics, Inc. | 01 Jul 2022 | 1 | $0 | 4 | Director | 05 Jul 2022, 16:05 |
| ZVRA | KEMPHARM, INC | 28 Jun 2022 | 1 | $0 | 4 | Director | 30 Jun 2022, 17:19 |
| ARTL | ARTELO BIOSCIENCES, INC. | 24 Jun 2022 | 1 | $0 | 4 | Director | 27 Jun 2022, 17:17 |
| ZVRA | KEMPHARM, INC | 20 May 2022 | 1 | +$974 | 4 | Director | 24 May 2022, 20:58 |
| HURA | Kintara Therapeutics, Inc. | 22 Sep 2021 | 1 | $0 | 4 | Director | 22 Sep 2021, 20:37 |
| ZVRA | KEMPHARM, INC | 18 Aug 2021 | 0 | $0 | 3 | Director | 18 Aug 2021, 17:38 |
| ARTL | ARTELO BIOSCIENCES, INC. | 16 Jul 2021 | 1 | $0 | 4 | Director | 26 Jul 2021, 16:22 |